Reproductive Medicine Across Borders

ReproUnion is a cross-border collaboration between Sweden and Denmark within the area of reproductive medicine in the Øresund Region. During 15 years, the ReproUnion partnership has been collaborating across disciplines between academia, hospitals, and industry with more than 50 professors and researches involved.

Our aim is to understand the underlying reasons of infertility and to personalise and improve reproductive treatment. To do so, ReproUnion is building an innovation platform to help the industry gain access to cutting-edge expertise and research infrastructure. This entrepreneurial setting is also inspiring the utilization of public research in patents and future spin-outs.

Public-private partnerships like ReproUnion are an important part of the solution to the challenges facing our healthcare systems. It´s about innovation and growth, but first and foremost it´s about putting patients´ needs first!

ReproUnion is funded by EU Interreg Interreg Öresund-Kattegat-Skagerrak, the Capital Region of Denmark, Region Skåne and Ferring Pharmaceuticals.

Successful collaboration during 15 years

The Øresund Region – also known as the Medicon Valley – has a high international position within reproductive medicine and is by many considered to be a frontrunner in the field. During 15 years, the region has developed and gained momentum from ReproSund through ReproHigh and ReproUnion with funding from EU Interreg programmes.

• ReproSund (2010-2013)
• ReproHigh (2012-2014): ‘Oresund Award in Health from the Capital Region of Denmark and the Region Skane.
• ReproUnion 1.0 (2015-2018): Funding of 22 ph.d./postdoc projects.
• ReproUnion 2.0 (2019-2022): Building fertility awareness and establishing the ReproUnion Biobank & Infertlity Cohort.
• ReproUnion 3.0 (2023-2026): Developing a Platform for Driving Reproductive Health Innovation.